Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery
The integrated imaging...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery
The integrated imaging...
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.
The pilot study enrolled 10 patients with chronic venous disease (CEAP classification C2-C4) requiring ablation of the great saphenous vein (GSV) due to abnormal reflux, who were followed for one year.
The pilot study enrolled 10 patients with chronic venous disease (CEAP classification C2-C4) requiring ablation of the great saphenous vein (GSV) due to abnormal reflux, who were followed for one year.
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Conavi’s next-generation hybrid imaging system integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. These technologies together enable physicians to visualize both deep vessel structures...
Conavi’s next-generation hybrid imaging system integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. These technologies together enable physicians to visualize both deep vessel structures...
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
A UCLA team of bioengineers, computer scientists, and physicians designed a stent to be implanted during an angioplasty and powered by the natural pulsing of blood through the artery.
A UCLA team of bioengineers, computer scientists, and physicians designed a stent to be implanted during an angioplasty and powered by the natural pulsing of blood through the artery.
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
DEEPER REVEAL is a prospective, non-randomized, multicenter study evaluating use of the Spur Peripheral Retrievable Stent System following predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK)...
